OvaScience Company Profile (NASDAQ:OVAS)

About OvaScience

OvaScience logoOvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's own ovarian tissue. The Company's AUGMENT treatment is designed to improve egg health by supplementing a mitochondrial deficiency. With the AUGMENT treatment, energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs during the in vitro fertilization process to supplement the existing mitochondria. Its OvaPrime treatment is a fertility treatment designed to replenish a woman's ovary by increasing her egg reserve using her own EggPC cells. Its OvaTure treatment is a fertility treatment that seeks to create mature fertilizable eggs in vitro from a woman's own EggPC cells without the need for hormone hyperstimulation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OVAS
  • CUSIP:
Key Metrics:
  • Previous Close: $1.48
  • 50 Day Moving Average: $1.57
  • 200 Day Moving Average: $4.22
  • 52-Week Range: $1.30 - $11.66
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.94
  • P/E Growth: 0.00
  • Market Cap: $52.70M
  • Outstanding Shares: 35,608,000
  • Beta: 3.73
Profitability:
  • Net Margins: -11,642.67%
  • Return on Equity: -62.66%
  • Return on Assets: -57.12%
Debt:
  • Current Ratio: 11.85%
  • Quick Ratio: 11.85%
Additional Links:
Companies Related to OvaScience:

Analyst Ratings

Consensus Ratings for OvaScience (NASDAQ:OVAS) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $7.94 (436.71% upside)

Analysts' Ratings History for OvaScience (NASDAQ:OVAS)
Show:
DateFirmActionRatingPrice TargetDetails
12/25/2016Oppenheimer Holdings, Inc.Reiterated RatingHoldView Rating Details
11/6/2016HC WainwrightReiterated RatingBuyView Rating Details
8/10/2016JMP SecuritiesReiterated RatingNeutralView Rating Details
8/5/2016J P Morgan Chase & CoLower Price TargetNeutral$9.00 -> $8.00View Rating Details
7/12/2016Credit Suisse GroupReiterated RatingSellView Rating Details
5/8/2016Leerink SwannReiterated RatingHold$6.00 -> $7.00View Rating Details
3/21/2016S&P Equity ResearchLower Price Target$10.82 -> $8.83View Rating Details
10/2/2015WedbushLower Price TargetOutperform$46.00 -> $15.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for OvaScience (NASDAQ:OVAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/2/2017        
11/3/2016Q316($0.62)($0.54)$0.25 million$0.02 millionViewListenView Earnings Details
8/4/2016Q216($0.78)($0.62)$0.21 million$0.19 millionViewListenView Earnings Details
5/5/2016Q116($0.72)($0.80)$0.14 million$0.15 millionViewListenView Earnings Details
2/25/2016Q315($0.71)($0.76)$0.27 millionViewListenView Earnings Details
11/5/2015Q3($0.68)($0.66)$0.17 million$0.08 millionViewN/AView Earnings Details
8/10/2015Q215($0.64)($0.64)ViewN/AView Earnings Details
5/11/2015($0.65)($0.65)$0.40 million$0.02 millionViewN/AView Earnings Details
3/16/2015Q414($0.59)($0.79)ViewN/AView Earnings Details
11/10/2014Q314($0.44)($0.54)ViewN/AView Earnings Details
8/7/2014Q214($0.45)($0.42)ViewN/AView Earnings Details
5/8/2014($0.46)($0.41)ViewN/AView Earnings Details
2/27/2014Q413($0.39)($0.64)ViewN/AView Earnings Details
11/13/2013Q313($0.35)($0.40)ViewN/AView Earnings Details
8/13/2013Q213($0.28)($0.36)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OvaScience (NASDAQ:OVAS)
Current Year EPS Consensus Estimate: $-2.50 EPS
Next Year EPS Consensus Estimate: $-1.57 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.81)($0.81)($0.81)
Q3 20161($0.81)($0.81)($0.81)
Q4 20161($0.69)($0.69)($0.69)
Q1 20171($0.35)($0.35)($0.35)
Q2 20171($0.35)($0.35)($0.35)
Q3 20171($0.34)($0.34)($0.34)
Q4 20171($0.34)($0.34)($0.34)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OvaScience (NASDAQ:OVAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OvaScience (NASDAQ:OVAS)
Insider Ownership Percentage: 12.59%
Institutional Ownership Percentage: 79.61%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2016Michelle DippCEOBuy425,000$7.00$2,975,000.00View SEC Filing  
5/18/2016Michelle DippCEOBuy20,000$7.86$157,200.00View SEC Filing  
5/17/2016Michelle DippCEOBuy40,000$7.63$305,200.00View SEC Filing  
5/13/2016Richard AldrichDirectorBuy36,095$6.94$250,499.30View SEC Filing  
5/11/2016Richard AldrichDirectorBuy20,000$7.64$152,800.00View SEC Filing  
5/10/2016Michelle DippCEOBuy19,900$7.72$153,628.00View SEC Filing  
5/10/2016Paul W.D. ChapmanCOOBuy3,100$7.37$22,847.00View SEC Filing  
3/24/2016Michelle DippCEOBuy59,800$9.49$567,502.00View SEC Filing  
3/22/2016Michelle DippCEOBuy59,800$10.44$624,312.00View SEC Filing  
3/18/2016Michelle DippCEOBuy59,700$8.26$493,122.00View SEC Filing  
3/16/2016Michelle DippCEOBuy59,029$7.90$466,329.10View SEC Filing  
3/14/2016Michelle DippCEOBuy162,732$7.60$1,236,763.20View SEC Filing  
10/5/2015Jeffrey E YoungCFOBuy3,450$10.70$36,915.00View SEC Filing  
10/5/2015Marc D KozinDirectorBuy4,800$10.79$51,792.00View SEC Filing  
9/9/2015Mary FisherDirectorBuy6,100$16.49$100,589.00View SEC Filing  
9/8/2015Marc D KozinDirectorBuy3,000$17.60$52,800.00View SEC Filing  
4/8/2015Marc D KozinDirectorBuy3,000$28.45$85,350.00View SEC Filing  
4/2/2015Michelle DippCEOBuy1,000$32.49$32,490.00View SEC Filing  
1/13/2015Thomas MalleyDirectorBuy35,000$50.00$1,750,000.00View SEC Filing  
7/7/2014Richard AldrichDirectorBuy2,000$9.49$18,980.00View SEC Filing  
6/30/2014Richard AldrichDirectorBuy2,000$9.16$18,320.00View SEC Filing  
6/23/2014Richard AldrichDirectorBuy2,000$8.81$17,620.00View SEC Filing  
6/16/2014Richard AldrichDirectorBuy2,000$8.52$17,040.00View SEC Filing  
6/9/2014Richard AldrichDirectorBuy2,000$7.59$15,180.00View SEC Filing  
6/3/2014Harald F StockDirectorBuy1,063$7.01$7,451.63View SEC Filing  
6/2/2014Richard AldrichDirectorBuy2,000$7.29$14,580.00View SEC Filing  
5/27/2014Richard AldrichDirectorBuy2,000$7.50$15,000.00View SEC Filing  
5/20/2014Harald F StockDirectorBuy1,050$7.13$7,486.50View SEC Filing  
5/19/2014Richard AldrichDirectorBuy2,000$7.33$14,660.00View SEC Filing  
3/7/2014Fund L.P. LongwoodMajor ShareholderBuy100,000$10.00$1,000,000.00View SEC Filing  
9/12/2013Arthur TzianabosInsiderBuy1,000$10.32$10,320.00View SEC Filing  
9/12/2013Harald F StockDirectorBuy4,500$10.64$47,880.00View SEC Filing  
9/11/2013Christopher A BleckInsiderBuy2,000$11.15$22,300.00View SEC Filing  
9/11/2013Richard AldrichDirectorBuy4,850$10.54$51,119.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for OvaScience (NASDAQ:OVAS)
DateHeadline
News IconNASDAQ:OVAS Investor Alert: Investigation over Potential Wrongdoing at OvaScience Inc (NASDAQ:OVAS)
www.military-technologies.net - February 24 at 8:09 PM
finance.yahoo.com logoOvaScience to Host Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call (NASDAQ:OVAS)
finance.yahoo.com - February 23 at 7:08 PM
News IconIn- Vitro Fertilization Global Market Research Methodology, Research Scope Forecast 2022 (NASDAQ:OVAS)
www.emailwire.com - February 21 at 5:48 PM
investornewswire.com logoSentiments And Ratings Alert: Ovascience Inc. (NASDAQ:OVAS) - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - February 18 at 6:15 PM
News IconShares Bending Lower in Session: OvaScience, Inc. (NASDAQ:OVAS) - Aiken Advocate (NASDAQ:OVAS)
aikenadvocate.com - February 16 at 11:43 PM
News IconMarket Update: Watching Increased Volatility on Shares of OvaScience, Inc. (NASDAQ:OVAS) - Aiken Advocate (NASDAQ:OVAS)
aikenadvocate.com - February 16 at 6:42 PM
businesswire.com logoNewman Ferrara LLP Announces Corporate Governance Investigation of OvaScience, Inc. - Business Wire (press release) (NASDAQ:OVAS)
www.businesswire.com - February 16 at 6:42 PM
finance.yahoo.com logoNewman Ferrara LLP Announces Corporate Governance Investigation of OvaScience, Inc. (NASDAQ:OVAS)
finance.yahoo.com - February 14 at 10:55 PM
investornewswire.com logoOvascience Inc. (NASDAQ:OVAS) EPS Target At $-0.34 - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - February 3 at 7:54 PM
News IconOvascience Inc. (NASDAQ:OVAS) Quarterly EPS Projection At $-0.62 - Stock Observer (NASDAQ:OVAS)
www.thestockobserver.com - February 3 at 7:54 PM
istreetwire.com logoStocks Under Consideration: Energen Corporation (EGN), Chimera ... - iStreetWire (NASDAQ:OVAS)
istreetwire.com - February 2 at 8:01 PM
News IconBargain Hunter's Delight: What's the Latest on OvaScience, Inc ... - Prospect Journal (NASDAQ:OVAS)
prospectjournal.com - February 1 at 8:14 PM
News IconNews Impact Score Of Ovascience Inc. (NASDAQ:OVAS) At 50 - Stock Observer (NASDAQ:OVAS)
www.thestockobserver.com - February 1 at 8:14 PM
News IconGlobal In-Vitro Fertilization (IVF) Market Review & 2015-2022 Forecast Study (NASDAQ:OVAS)
www.medgadget.com - January 31 at 8:06 PM
News IconIs This Stock Capable of a Bull Run: OvaScience, Inc. (NASDAQ:OVAS) - Nelson Research (NASDAQ:OVAS)
nelsonobserver.com - January 31 at 12:46 AM
News IconCan This Stock Make a Ripple in the Market: OvaScience, Inc ... - Prospect Journal (NASDAQ:OVAS)
prospectjournal.com - January 31 at 12:46 AM
News IconNotable Stock For Under $5: OvaScience, Inc. (NASDAQ:OVAS ... - Prospect Journal (NASDAQ:OVAS)
prospectjournal.com - January 31 at 12:46 AM
News IconROE of Cellectar Biosciences, Inc. (NASDAQ:CLRB) stands at -48 (NASDAQ:OVAS)
nflnewsdesk.com - January 27 at 6:03 AM
investornewswire.com logoStrong Sell Recommendations Of Ovascience Inc. (NASDAQ:OVAS) At 0 - Investor Newswire (NASDAQ:OVAS)
www.investornewswire.com - January 24 at 7:53 PM
prnewswire.com logoBiotech Stocks Under Scanner -- Kite Pharma, BioPharmX ... - PR Newswire (press release) (NASDAQ:OVAS)
www.prnewswire.com - January 23 at 9:36 AM
News IconNews Impact Score Of Ovascience Inc. (NASDAQ:OVAS) Set At 50 ... - Stock Observer (NASDAQ:OVAS)
www.thestockobserver.com - January 20 at 7:54 PM
News IconNear-Term, Can This Stock Move the Needle: OvaScience, Inc. (NASDAQ:OVAS) - Prospect Journal (NASDAQ:OVAS)
prospectjournal.com - January 19 at 5:43 AM
News IconIs the Needle Ready to Move for OvaScience, Inc. (NASDAQ:OVAS) - Prospect Journal (NASDAQ:OVAS)
prospectjournal.com - January 18 at 8:44 AM
News IconStock Perspective: Ovascience Inc. (NASDAQ:OVAS) Earnings in View - Aiken Advocate (NASDAQ:OVAS)
aikenadvocate.com - January 17 at 7:29 PM
News IconInvestors Priming the Pump as Stock Reaches Most Volatile List: OvaScience, Inc. (NASDAQ:OVAS) - Wall Street Beacon (NASDAQ:OVAS)
wsbeacon.com - January 17 at 7:29 PM
News IconThe Gilead Sciences Inc. (GILD) Coverage Initiated at the Stifel Nicolaus (NASDAQ:OVAS)
onemma.net - January 14 at 4:59 AM
einnews.com logoGlobal In- Vitro Fertilization (IVF) Market 2017 Share, Trend, Segmentation and Forecast to 2021 (NASDAQ:OVAS)
www.einnews.com - January 14 at 4:59 AM
bizjournals.com logoTroubled fertility biotech OvaScience offers CFO cash bonus not to leave (NASDAQ:OVAS)
www.bizjournals.com - January 13 at 11:58 PM
News IconWill The Needle Move For Ovascience Inc. (NASDAQ:OVAS) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:OVAS)
wsbeacon.com - January 13 at 5:49 AM
News IconIs This Equity Ready for a Breakout: OvaScience, Inc. (NASDAQ:OVAS) - Prospect Journal (NASDAQ:OVAS)
prospectjournal.com - January 13 at 5:49 AM
News IconStock Getting Tripped Up In Session: OvaScience, Inc. (NASDAQ:OVAS) - Wall Street Beacon (NASDAQ:OVAS)
wsbeacon.com - January 12 at 12:44 AM
News IconNews Impact Score Of Ovascience Inc. (NASDAQ:OVAS) Set At 50 - Stock Observer (NASDAQ:OVAS)
www.thestockobserver.com - January 12 at 12:44 AM
News IconStock Reaching Most Volatile List Today: OvaScience, Inc. (NASDAQ:OVAS) - Wall Street Beacon (NASDAQ:OVAS)
wsbeacon.com - January 12 at 12:44 AM
News IconWhich Direction is This Stock Headed? Update on OvaScience, Inc. (NASDAQ:OVAS) - Prospect Journal (NASDAQ:OVAS)
prospectjournal.com - January 12 at 12:44 AM
streetinsider.com logoForm SC 13G/A OvaScience, Inc. Filed by: PRUDENTIAL FINANCIAL INC (NASDAQ:OVAS)
www.streetinsider.com - January 10 at 7:59 PM
streetinsider.com logoForm SC 13G/A OvaScience, Inc. Filed by: JENNISON ASSOCIATES LLC - StreetInsider.com (NASDAQ:OVAS)
www.streetinsider.com - January 10 at 8:36 AM
streetinsider.com logoForm 4 OvaScience, Inc. For: Jan 05 Filed by: Couturier Christophe - StreetInsider.com (NASDAQ:OVAS)
www.streetinsider.com - January 10 at 8:36 AM
marketexclusive.com logoOvaScience, Inc. (NASDAQ:OVAS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors ... - Market Exclusive (NASDAQ:OVAS)
marketexclusive.com - January 10 at 8:36 AM
biz.yahoo.com logoOVASCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:OVAS)
biz.yahoo.com - January 10 at 8:36 AM
News IconIn- Vitro Fertilization Global Market Key Developments, Outlook, Analysis & Forecast to 2022 (NASDAQ:OVAS)
www.emailwire.com - January 7 at 5:49 AM
News IconOvascience Inc. (NASDAQ:OVAS) News Impact Score At 50 - Stock Observer (NASDAQ:OVAS)
www.thestockobserver.com - January 6 at 7:47 PM
finance.yahoo.com logoOvaScience to Present at the 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:OVAS)
finance.yahoo.com - January 5 at 11:50 PM
News IconPlacing the Bulls-Eye Focus on OvaScience, Inc. (NASDAQ:OVAS) - Prospect Journal (NASDAQ:OVAS)
prospectjournal.com - January 3 at 11:43 PM
News IconWhat are Analysts opinions on: McEwen Mining Inc. (NYSE:MUX) (NASDAQ:OVAS)
perspectivabetica.com - December 29 at 7:03 PM
News IconOvaScience Biotech Blogger Making Positive Tweet (NASDAQ:OVAS)
www.guerillastocktrading.com - December 29 at 7:03 PM
News IconAsia Pacific IVF services market is estimated to reach $7.1 billion by 2022 (NASDAQ:OVAS)
empowerednews.net - December 28 at 6:57 PM
finance.yahoo.com logoImplied Volatility Surging for OvaScience (OVAS) Stock Options (NASDAQ:OVAS)
finance.yahoo.com - December 27 at 9:51 AM
wallstrt24.com logoStocks in Focus Wal-Mart Stores, Inc. (NYSE:WMT), OvaScience Inc (NASDAQ:OVAS) - Wall Street 24 (NASDAQ:OVAS)
wallstrt24.com - December 26 at 6:28 PM
marketexclusive.com logoOvaScience,Inc. (NASDAQ:OVAS) Files An 8-K Costs Associated ... - Market Exclusive (NASDAQ:OVAS)
marketexclusive.com - December 26 at 9:44 AM
News IconStock under Radar: Ovascience Inc. (NASDAQ:OVAS), Intel Corporation (NASDAQ:INTC) - The Newburgh Press (NASDAQ:OVAS)
newburghpress.com - December 25 at 6:24 PM

Social

What is OvaScience's stock symbol?

OvaScience trades on the NASDAQ under the ticker symbol "OVAS."

Where is OvaScience's stock going? Where will OvaScience's stock price be in 2017?

6 analysts have issued 1 year price objectives for OvaScience's shares. Their forecasts range from $7.00 to $8.83. On average, they anticipate OvaScience's share price to reach $7.94 in the next twelve months.

When will OvaScience announce their earnings?

OvaScience is scheduled to release their next quarterly earnings announcement on Thursday, March, 2nd 2017.

Who owns OvaScience stock?

OvaScience's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (15.00%), Franklin Resources Inc. (1.79%), State Street Corp (1.35%), Third Security LLC (1.05%), Tudor Investment Corp Et Al (0.95%) and Employees Retirement System of Texas (0.25%). Company insiders that own OvaScience stock include Jeffrey E Young, Marc D Kozin, Mary Fisher, Michelle Dipp, Paul WD Chapman and Richard Aldrich.

Who bought OvaScience stock? Who is buying OvaScience stock?

OvaScience's stock was acquired by a variety of institutional investors in the last quarter, including Third Security LLC, Tudor Investment Corp Et Al, FMR LLC and State Street Corp. Company insiders that have bought OvaScience stock in the last two years include Jeffrey E Young, Marc D Kozin, Mary Fisher, Michelle Dipp, Paul WD Chapman and Richard Aldrich.

How do I buy OvaScience stock?

Shares of OvaScience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of OvaScience stock cost?

One share of OvaScience stock can currently be purchased for approximately $1.48.

OvaScience (NASDAQ:OVAS) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for OvaScience (NASDAQ:OVAS)

Earnings History Chart

Earnings by Quarter for OvaScience (NASDAQ:OVAS)

Dividend History Chart

Dividend Payments by Quarter for OvaScience (NASDAQ:OVAS)

Last Updated on 2/25/2017 by MarketBeat.com Staff